Barbara S. Bushey

A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung Tumors.

P. Parren, M. Chiu, L. Luistro, 2016, Cancer research.

Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis

K. Packman, B. Henley, M. Beqiri, 2020, Molecular Cancer Therapeutics.

Fc-mediated activity of EGFR x c-Met bispecific antibody JNJ-61186372 enhanced killing of lung cancer cells

M. Chiu, J. Pardinas, S. Laquerre, 2016, mAbs.

Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody*

M. Chiu, E. Lacy, Manuel A. Sepulveda, 2015, The Journal of Biological Chemistry.

Relative antigen levels affect bispecific antibody behavior 1 Impact of Cell-Surface Antigen Expression on Target Engagement and Function of an EGFR x c-Met Bispecific Antibody *

M. Chiu, E. Lacy, Manuel A. Sepulveda, 2015 .

Everyday reasoning and the roots of intelligence

David N. Perkins, D. Perkins, Michael Farady, 1991 .